Reply to a letter to the editor

Affiliations

¹ Biophysics Department, Faculty of Science, Cairo University, Giza, Egypt; The International Center for Theoretical Physics (ICTP), Trieste, Italy. Electronic address: abdo@sci.cu.edu.eg.

Comment

Abdo A Elfiky. Life Sci. 2020.

. 2020 Jul 1:252:117715.

doi: 10.1016/j.lfs.2020.117715. Epub 2020 Apr 22.

¹ Biophysics Department, Faculty of Science, Cairo University, Giza, Egypt; The International Center for Theoretical Physics (ICTP), Trieste, Italy. Electronic address: abdo@sci.cu.edu.eg.

No abstract available

Comment on

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.
Elfiky AA. Elfiky AA. Life Sci. 2020 Jul 15;253:117592. doi: 10.1016/j.lfs.2020.117592. Epub 2020 Mar 25. Life Sci. 2020. PMID: 32222463 Free PMC article.
Letter to the editor.
De Clercq E. De Clercq E. Life Sci. 2020 Jul 1;252:117714. doi: 10.1016/j.lfs.2020.117714. Epub 2020 Apr 22. Life Sci. 2020. PMID: 32334012 Free PMC article. No abstract available.

1. Oprea T.I., Bauman J.E., Bologa C.G., Buranda T., Chigaev A., Edwards B.S., Jarvik J.W., Gresham H.D., Haynes M.K., Hjelle B. Drug repurposing from an academic perspective. Drug Discov. Today Ther. Strateg. 2011;8:61–69. - PMC - PubMed
1. Pushpakom S., Iorio F., Eyers P.A., Escott K.J., Hopper S., Wells A., Doig A., Guilliams T., Latimer J., McNamee C. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 2019;18:41–58. - PubMed
1. Acharya K.R., Sturrock E.D., Riordan J.F., Ehlers M.R.W. Ace revisited: a new target for structure-based drug design. Nat. Rev. Drug Discov. 2003;2:891–902. - PMC - PubMed
1. Kuntz I.D. Structure-based strategies for drug design and discovery. Science (New York, N.Y.) 1992;257:1078–1082. - PubMed
1. Cihlar T., Ray A.S. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antivir. Res. 2010;85:39–58. - PubMed